Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001641172-25-017833

Options or other derivatives

  • Chief Medical Officer acquired 63,636 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Agah Ramtin Chief Medical Officer 2025-07-01 Grant or award · Stock Option +63,636 63,636 D
Loading xslF345X05/ownership.xml…